The University of Pennsylvania spinout said it has no intention to resume research and development work. To continue reading ...

Carrick (personal) was absent from Monday's practice, Colin Stephenson of Newsday reports. The Rangers recalled Nicolas Aube-Kubel from AHL Hartford on Monday, which suggests that Carrick could ...

Carrick is awaiting the birth of his child and won't play Tuesday versus the Kings, Colin Stephenson of Newsday reports. It's unclear if Carrick will remain away from the team for the rest of ...

Michael Carrick says no decision has yet been made on Anfernee Dijksteel’s Middlesbrough future, as his current deal runs down. Dijksteel is out of contract with Boro at the end of the season ...

Carrick Rangers goalkeeper Jack McIntyre has apologised for the incident in Saturday's Irish Premiership game against Cliftonville in which a ball boy appeared to be pushed to the ground.

Michael Carrick was in no mood to defend his Middlesbrough players after their defeat to Swansea City, admitting they deserved nothing from the game in an uncharacteristic performance. Admitting ...

It does not necessarily reflect the view of The Herald. MICHAEL CARRICK felt compelled to make two half-time changes during Middlesbrough’s 1-0 defeat at Swansea City yesterday – but insists ...

D. Boral Capital lowered the firm’s price target on Carisma Therapeutics (CARM) to $1 from $12 and keeps a Buy rating on the shares after the ...

Mizuho Securities analyst Uy Ear maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report) today and set a price target of $190.00. The company’s shares closed last Friday at ...

Kyverna Therapeutics logo (PRNewsfoto/Kyverna Therapeutics) "Kyverna's first year as a public company was a transformative one, as we demonstrated our leadership position in autoimmune CAR T.